Cargando…
Hepatocellular Carcinoma in Malaysia and Its Changing Trend
Hepatocellular carcinoma (HCC) is one of the leading causes of death globally. In Malaysia liver cancer is the eighth most common cause of cancer for both gender and fifth most common cause of cancer for males. Liver cancer is a cause of premature death in Malaysia: The trend from 1990 to 2010 was o...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024046/ https://www.ncbi.nlm.nih.gov/pubmed/29963463 http://dx.doi.org/10.5005/jp-journals-10018-1259 |
_version_ | 1783335982889697280 |
---|---|
author | Raihan, Ruksana Azzeri, Amirah H Shabaruddin, Fatiha Mohamed, Rosmawati |
author_facet | Raihan, Ruksana Azzeri, Amirah H Shabaruddin, Fatiha Mohamed, Rosmawati |
author_sort | Raihan, Ruksana |
collection | PubMed |
description | Hepatocellular carcinoma (HCC) is one of the leading causes of death globally. In Malaysia liver cancer is the eighth most common cause of cancer for both gender and fifth most common cause of cancer for males. Liver cancer is a cause of premature death in Malaysia: The trend from 1990 to 2010 was observed upward. Since 1990, the annual years of life lost (YLLs) from liver cancer have increased by 31.5%. Older persons are at higher risk and there is male predominance observed. Curative surgical resection, liver transplantation, and supportive symptomatic care, including percutaneous ethanol injection and radiofrequency ablation (RFA), and noncurative transarterial chemoembolization (TACE) are among available treatment facilities. Yet the survival rate is very poor as majority of patients present at very advanced stage. Hepatitis B virus (HBV) remained the leading cause of HCC in Malaysia. Several studies showed cryptogenic causes, which are mainly nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) among the predominant causes of HCC in Malaysia than hepatitis C virus (HCV), alcohol, or any other reason. This mainly correlates with the increasing incidence of diabetes and obesity in Malaysia. How to cite this article: Raihan R, Azzeri A, Shabaruddin FH, Mohamed R. Hepatocellular Carcinoma in Malaysia and Its Changing Trend. Euroasian J Hepato-Gastroenterol 2018;8(1):54-56. |
format | Online Article Text |
id | pubmed-6024046 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Jaypee Brothers Medical Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-60240462018-06-30 Hepatocellular Carcinoma in Malaysia and Its Changing Trend Raihan, Ruksana Azzeri, Amirah H Shabaruddin, Fatiha Mohamed, Rosmawati Euroasian J Hepatogastroenterol Mini-Review Hepatocellular carcinoma (HCC) is one of the leading causes of death globally. In Malaysia liver cancer is the eighth most common cause of cancer for both gender and fifth most common cause of cancer for males. Liver cancer is a cause of premature death in Malaysia: The trend from 1990 to 2010 was observed upward. Since 1990, the annual years of life lost (YLLs) from liver cancer have increased by 31.5%. Older persons are at higher risk and there is male predominance observed. Curative surgical resection, liver transplantation, and supportive symptomatic care, including percutaneous ethanol injection and radiofrequency ablation (RFA), and noncurative transarterial chemoembolization (TACE) are among available treatment facilities. Yet the survival rate is very poor as majority of patients present at very advanced stage. Hepatitis B virus (HBV) remained the leading cause of HCC in Malaysia. Several studies showed cryptogenic causes, which are mainly nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) among the predominant causes of HCC in Malaysia than hepatitis C virus (HCV), alcohol, or any other reason. This mainly correlates with the increasing incidence of diabetes and obesity in Malaysia. How to cite this article: Raihan R, Azzeri A, Shabaruddin FH, Mohamed R. Hepatocellular Carcinoma in Malaysia and Its Changing Trend. Euroasian J Hepato-Gastroenterol 2018;8(1):54-56. Jaypee Brothers Medical Publishers 2018 2018-05-01 /pmc/articles/PMC6024046/ /pubmed/29963463 http://dx.doi.org/10.5005/jp-journals-10018-1259 Text en Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd. This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/ |
spellingShingle | Mini-Review Raihan, Ruksana Azzeri, Amirah H Shabaruddin, Fatiha Mohamed, Rosmawati Hepatocellular Carcinoma in Malaysia and Its Changing Trend |
title | Hepatocellular Carcinoma in Malaysia and Its Changing Trend |
title_full | Hepatocellular Carcinoma in Malaysia and Its Changing Trend |
title_fullStr | Hepatocellular Carcinoma in Malaysia and Its Changing Trend |
title_full_unstemmed | Hepatocellular Carcinoma in Malaysia and Its Changing Trend |
title_short | Hepatocellular Carcinoma in Malaysia and Its Changing Trend |
title_sort | hepatocellular carcinoma in malaysia and its changing trend |
topic | Mini-Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024046/ https://www.ncbi.nlm.nih.gov/pubmed/29963463 http://dx.doi.org/10.5005/jp-journals-10018-1259 |
work_keys_str_mv | AT raihanruksana hepatocellularcarcinomainmalaysiaanditschangingtrend AT azzeriamirah hepatocellularcarcinomainmalaysiaanditschangingtrend AT hshabaruddinfatiha hepatocellularcarcinomainmalaysiaanditschangingtrend AT mohamedrosmawati hepatocellularcarcinomainmalaysiaanditschangingtrend |